Ligand Pharmaceuticals Inc financial data

Symbol
LGND on Nasdaq, LGNDZ, LGNXZ, LGNYZ, LGNZZ on OTC
Location
3911 Sorrento Valley Blvd, Suite 110, San Diego, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 8, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 703 % -58.7%
Quick Ratio 32.9 % -74.6%
Debt-to-equity 13.8 % +5.5%
Return On Equity -9.21 % -261%
Return On Assets -8.09 % -260%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 19.6M shares +7.27%
Common Stock, Shares, Outstanding 19.4M shares +7.23%
Entity Public Float 1.1B USD +22.2%
Common Stock, Value, Issued 20K USD +5.26%
Weighted Average Number of Shares Outstanding, Basic 19.3M shares +7.21%
Weighted Average Number of Shares Outstanding, Diluted 19.9M shares +10.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 188M USD +40.5%
Research and Development Expense 66.8M USD +199%
General and Administrative Expense 89.1M USD +50.4%
Operating Income (Loss) -34.3M USD -109%
Nonoperating Income (Expense) -50.2M USD -172%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -84.5M USD -259%
Income Tax Expense (Benefit) -8.63M USD -179%
Net Income (Loss) Attributable to Parent -75.9M USD -280%
Earnings Per Share, Basic -4 USD/shares -273%
Earnings Per Share, Diluted -4 USD/shares -273%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 67.7M USD +273%
Accounts Receivable, after Allowance for Credit Loss, Current 41.3M USD +10.2%
Inventory, Net 15.5M USD -17%
Other Assets, Current 4.82M USD -32.4%
Assets, Current 353M USD +13%
Deferred Income Tax Assets, Net 829K USD +336%
Property, Plant and Equipment, Net 3.63M USD -75.7%
Operating Lease, Right-of-Use Asset 7.99M USD +7.94%
Intangible Assets, Net (Excluding Goodwill) 250M USD -11.7%
Goodwill 102M USD -3.52%
Other Assets, Noncurrent 9.11M USD -23.6%
Assets 949M USD +9.49%
Accounts Payable, Current 8.58M USD +379%
Employee-related Liabilities, Current 2.51M USD -6.4%
Accrued Liabilities, Current 17.5M USD +43.5%
Contract with Customer, Liability, Current 111K USD -90.7%
Liabilities, Current 64.7M USD +249%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Deferred Income Tax Liabilities, Net 32.2M USD +7.03%
Operating Lease, Liability, Noncurrent 4.63M USD -27.8%
Other Liabilities, Noncurrent 14.4M USD -51%
Liabilities 120M USD +31.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 8.49M USD
Retained Earnings (Accumulated Deficit) 461M USD -14.1%
Stockholders' Equity Attributable to Parent 829M USD +6.88%
Liabilities and Equity 949M USD +9.49%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -25.4M USD -236%
Net Cash Provided by (Used in) Financing Activities -4.75M USD -139%
Net Cash Provided by (Used in) Investing Activities 4.89M USD
Common Stock, Shares Authorized 60M shares 0%
Common Stock, Shares, Issued 19.4M shares +7.23%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 27.1M USD -37.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 67.7M USD +273%
Interest Paid, Excluding Capitalized Interest, Operating Activities 97K USD +64.4%
Deferred Tax Assets, Valuation Allowance 55.6M USD -3.55%
Deferred Tax Assets, Gross 96.3M USD -7.15%
Operating Lease, Liability 7.08M USD +15%
Payments to Acquire Property, Plant, and Equipment 214K USD +104%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -66.4M USD -258%
Lessee, Operating Lease, Liability, to be Paid 9.48M USD +7.57%
Property, Plant and Equipment, Gross 23.4M USD +5.12%
Operating Lease, Liability, Current 1.09M USD -5.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.64M USD +37.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.54M USD +46.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.98M USD -11.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.63M USD +33.3%
Deferred Tax Assets, Operating Loss Carryforwards 40.4M USD -11.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 14.3M USD -1.15%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.56M USD +23.8%
Additional Paid in Capital 359M USD +50.1%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 8.77M USD +0.06%
Deferred Tax Assets, Net of Valuation Allowance 40.7M USD -11.7%
Interest Expense 557K USD -55.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%